Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Epilepsy

  Free Subscription


Articles published in Rev Neurol

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    July 2022
  1. ARTEAGA-RODRIGUEZ C, Menine-Kubis M, Teixeira-Arteaga CB, Hernandez-Fustes OJ, et al
    Clinical characteristics of patients with epilepsy attending primary health care.
    Rev Neurol. 2022;75:7-12.
    PubMed     Abstract available


    June 2022
  2. ANAYA-GONZALEZ JL, Lopez-Munoz F, Carmona-Alvarez Builla E, Miniet-Castillo AE, et al
    [Correlation between clinical and tomographic variables in patients with neurocysticercosis. A study in a cohort of patients in Sierra Norte, Ecuador, between 2019 and 2020].
    Rev Neurol. 2022;74:383-391.
    PubMed     Abstract available


    May 2022
  3. MOSCOL G, Espino PH, Mayor LC, Burneo JG, et al
    [Epilepsy with catamenial pattern].
    Rev Neurol. 2022;74:303-311.
    PubMed     Abstract available


    April 2022
  4. CATALAN-AGUILAR J, Lozano-Garcia A, Gonzalez-Bono E, Villanueva V, et al
    Academic and employment insertion as a factor related to quality of life in patients with drug-resistant temporal lobe epilepsy.
    Rev Neurol. 2022;74:219-227.
    PubMed     Abstract available


    March 2022
  5. NOGUEIRA M, Melo C, Grangeia A, Magalhaes T, et al
    PURA syndrome in a child with severe developmental delay: a challenging diagnosis.
    Rev Neurol. 2022;74:170-173.
    PubMed     Abstract available


    December 2021
  6. TOLEDANO R, Gil-Nagel A
    [Treatment of epilepsy with perampanel: conversion from add-on therapy to monotherapy].
    Rev Neurol. 2021;73.
    PubMed     Abstract available


  7. SANABRIA-SANCHINEL AA, Escobar-Pineda ES, Oliveros I, Perdomo-Mendizabal AL, et al
    [Telemedicine and epilepsy: healthcare experience of a national reference center during the COVID-19 pandemic].
    Rev Neurol. 2021;73:390-393.
    PubMed     Abstract available


    October 2021
  8. CANO-LOPEZ I, Vazquez-Costa JF, Gutierrez A, Villanueva V, et al
    [Cognitive reserve as a modulating factor in the impact of surgery on visual memory and naming in temporal lobe epilepsy patients].
    Rev Neurol. 2021;73:267-274.
    PubMed     Abstract available


  9. FERNANDEZ-ALONSO C, Gonzalez-Martinez F, Alonso-Aviles R, Linan-Lopez M, et al
    [On the treatment of epileptic seizures in patients with epilepsy in hospital emergency departments].
    Rev Neurol. 2021;73:258-259.
    PubMed    


  10. NAVARRO-PEREZ MP, Viloria-Alebesque A

    Rev Neurol. 2021;73:259-260.
    PubMed    


    September 2021
  11. GARCIA-PENAS JJ, Gil Nagel-Rein A, Sanchez-Carpintero R, Villanueva-Haba V, et al
    Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
    Rev Neurol. 2021;73.
    PubMed     Abstract available


  12. CANTARIN-EXTREMERA V, Bernardino-Cuesta B, Martin-Villaescusa C, Melero-Llorente J, et al
    [Tuberous sclerosis complex: analysis of areas of involvement, treatment progress and translation to routine clinical practice in a cohort of paediatric patients].
    Rev Neurol. 2021;73:141-150.
    PubMed     Abstract available


    July 2021
  13. MARTINEZ-PIAS E, Castineira-Mourenza JA, Prieto-Gonzalez AJ, Rodriguez-Osorio X, et al
    [Temporal pole encephalocele, a surgical treatable cause of drug-resistant epilepsy].
    Rev Neurol. 2021;73:77-79.
    PubMed     Abstract available


  14. CARDENAL-MUNOZ E, Nabbout R, Boronat S, Lara-Herguedas J, et al
    Impact of COVID-19 on Spanish patients with Dravet syndrome and their caregivers: consequences of lockdown.
    Rev Neurol. 2021;73:57-65.
    PubMed     Abstract available


    June 2021
  15. NAVARRO-PEREZ MP, Viloria-Alebesque A, Garces-Anton E, Marin-Gracia M, et al
    [Emergency department management of epileptic seizures in patients with epilepsy].
    Rev Neurol. 2021;72:419-425.
    PubMed     Abstract available


    April 2021
  16. VILLANUEVA V, Carreno-Martinez M, Gil Nagel-Rein A, Lopez-Gonzalez FJ, et al
    New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol.
    Rev Neurol. 2021;72.
    PubMed     Abstract available


  17. HERNANDEZ-RUBIO L, Asensio-Asensio M, Tortosa-Conesa D, Alfaro-Saez A, et al
    [Alzemon: a prospective follow-up study of eslicarbazepine acetate monotherapy in patients with newly diagnosed epilepsy].
    Rev Neurol. 2021;72:263-268.
    PubMed     Abstract available


    March 2021
  18. SALAS-PUIG J, Sopelana D, Quintana M, Seijo-Raposo I, et al
    [Quality of life in adult patients with idiopathic generalised epilepsy. The EPILAK study].
    Rev Neurol. 2021;72:195-202.
    PubMed     Abstract available


    February 2021
  19. RAMIREZ K, Frangini P, Mesa T, Molina V, et al
    [Peri-ictal electrocardiographic alterations in paediatric epilepsy patients. A prospective study].
    Rev Neurol. 2021;72:105-111.
    PubMed     Abstract available


  20. VALENCIA-CALDERON C, Rumia-Arboix J, Conesa-Bertran G, Calderon-Valdiviezo A, et al
    [Current status of epilepsy surgery in Spain. Compendium and awareness].
    Rev Neurol. 2021;72:92-102.
    PubMed     Abstract available


    November 2020
  21. BELLO N, Calvo-Medina R, Mora-Ramirez MD, Ramos-Fernandez JM, et al
    [Epileptic status in paediatric patients: its developmental consequences and an epidemiological update].
    Rev Neurol. 2020;71:365-372.
    PubMed     Abstract available


  22. GARCIA-PENAS JJ, Smeyers-Dura P, Roldan-Aparicio S, Aparicio J, et al
    [The role of eslicarbazepine acetate in the treatment of focal-onset epilepsy in pediatric age: practical issues].
    Rev Neurol. 2020;71.
    PubMed     Abstract available


    October 2020
  23. SOTO-INSUGA V, Oses M, Castano-De la Mota C, Martinez-Bermejo A, et al
    [Breath-holding spell or epileptic seizure? A description of three girls with epileptic seizures triggered by anoxia].
    Rev Neurol. 2020;71:313-314.
    PubMed    


  24. RAMIREZ-MORENO JM
    [Epilepsy and vascular risk].
    Rev Neurol. 2020;71:298-312.
    PubMed     Abstract available


  25. SILVA LS, Valdoleiros SR, Torrao C, Costa D, et al
    [Mirror writing in epilepsy].
    Rev Neurol. 2020;71:276.
    PubMed    


    September 2020
  26. TORO-PEREZ J, Suller-Marti A, Herrera M, Bottan J, et al
    [Temporal plus epilepsy: a review].
    Rev Neurol. 2020;71:225-233.
    PubMed     Abstract available


  27. ALCON-GRASES M, Ferrer-Aliaga N, Salinas-Salvador B, Perez-Delgado R, et al
    [Early infantile epileptic encephalopathy due to ITPA mutation].
    Rev Neurol. 2020;71:197-198.
    PubMed    


    August 2020
  28. RAMIREZ-ZAMORA M, Veliz-Martinez V, Barahona GE, Mena ID, et al
    [Hemicerebellitis due to chikungunya associated with refractory status epilepticus in the paediatric age].
    Rev Neurol. 2020;71:123-124.
    PubMed    


    July 2020
  29. MORENO-SANCHEZ A, Pitarch-Roca E, Molina-Herranz D, Perez-Delgado R, et al
    [Atypical presentation of early childhood epileptic encephalopathy associated with the gene KCNT1].
    Rev Neurol. 2020;71:41-42.
    PubMed    


  30. CARTAGENA Y, Cardona-Gallon DC, Isaza SP, Ladino LD, et al
    [Exercise as a therapeutic strategy in epilepsy: a literature review].
    Rev Neurol. 2020;71:31-37.
    PubMed     Abstract available


    May 2020
  31. MARIN-ROMERO B, Tirapu-Ustarroz J, Chiofalo MF
    [Neuropsychological assessment protocol for adults in epilepsy surgery].
    Rev Neurol. 2020;70:341-347.
    PubMed     Abstract available


  32. SANTOS-PEYRET A, Duron RM, Sebastian-Diaz MA, Crail-Melendez D, et al
    [E-health tools to overcome the gap in epilepsy care before, during and after COVID-19 pandemics].
    Rev Neurol. 2020;70:323-328.
    PubMed     Abstract available


    February 2020
  33. ALEDO-SERRANO A, Mingorance A
    [Analysis of the family impact and needs of Dravet's syndrome in Spain].
    Rev Neurol. 2020;70:75-83.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: